Showing results (571-580 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|January 22, 2026
Desmoplastic infantile ganglioglioma/astrocytoma: Expanding the molecular and morphological spectrum with a novel BRAF fusionIbrahim Kulac, Cisel Aydin Mericoz, Berrin Babaoglu, et al.
Neuro-Oncology Advances|February 10, 2026
The influence of VEGFR-2 blockade and focused ultrasound blood-brain barrier opening on the glioma-immune landscapeKatherine M Nowak, Matthew R Hoch, Victoria R Breza, et al.
Neuro-Oncology Advances|February 2, 2026
Breaking down glioma primary cilia disassemblyMatthew R Sarkisian, Loic P Deleyrolle, Joshua J Breunig
Neuro-Oncology Advances|December 1, 2025
Cerebrospinal fluid cell-free DNA as a liquid biopsy tool for detecting and monitoring genomic alterations in thalamic colorectal cancer metastasesAli Gharibi Loron, Yooree Ha, Cecile Riviere-Cazaux, et al.
Neuro-Oncology Advances|December 1, 2025
Trends of hospital-based reporting of intracranial neoplasms in Nigeria from 1960 to 2024: A systematic review and pooled analysis of literaturesKehinde Alare, Samson Adedeji Afolabi, Busayo Adetunji, et al.
Neuro-Oncology Advances|December 16, 2024
Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scansKeyhan Najafian, Benjamin Rehany, Alexander Nowakowski, et al.
Neuro-Oncology Advances|January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trialAnnika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
Neuro-Oncology Advances|February 6, 2025
Mapping glioma's impact on cognition: Insights from macrostructure, microstructure, and beyondNuria Cayuela, Cristina Izquierdo, Lucía Vaquero, et al.
Neuro-Oncology Advances|February 5, 2025
Risk analysis of radiosurgery for vestibular schwannoma: Systematic review and comparative study of 10-year outcomesKevin M Guy, April A Pace, Derek S Tsang, et al.
Neuro-Oncology Advances|February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomesTyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Pageof 138